Invention Grant
- Patent Title: Conserved HBV and HCV sequences useful for gene silencing
-
Application No.: US10560377Application Date: 2004-06-10
-
Publication No.: US08350021B2Publication Date: 2013-01-08
- Inventor: Catherine J. Pachuk , Chandrasekhar Satishchandran , Vincent R. Zurawski, Jr. , Liat Mintz
- Applicant: Catherine J. Pachuk , Chandrasekhar Satishchandran , Vincent R. Zurawski, Jr. , Liat Mintz
- Applicant Address: US MA Cambridge
- Assignee: Alnylam Pharmaceuticals, Inc.
- Current Assignee: Alnylam Pharmaceuticals, Inc.
- Current Assignee Address: US MA Cambridge
- Agency: Nixon Peabody LLP
- Agent David S. Resnick; Mark J. FitzGerald
- International Application: PCT/US2004/019229 WO 20040610
- International Announcement: WO2005/014806 WO 20050217
- Main IPC: C07H21/04
- IPC: C07H21/04
Abstract:
Conserved consensus sequences from known hepatitis B virus strains and known hepatitis C virus strains, which are useful in inhibiting the expression of the viruses in mammalian cells, are provided. These sequences are useful to silence the genes of HBV and HCV, thereby providing therapeutic utility against HBV and HCV viral infection in humans.
Public/Granted literature
- US20080070854A1 Conserved Hbv and Hcv Sequences Useful for Gene Silencing Public/Granted day:2008-03-20
Information query
